Bladder cancer radiation trial halted after just 2 patients
Disease control
Terminated
This study tested a new type of radiation therapy that adjusts daily to target bladder cancer more precisely, aiming to reduce severe bowel and bladder side effects. It was designed for adults with muscle-invasive bladder cancer that hadn't spread. However, the trial was stopped …
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated May 12, 2026 13:40 UTC